Didier Samuel

Research interests

Publications

• Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial

  Nature Medicine · 2021 · https://doi.org/10.1038/s41591-021-01495-3

• Update of the statements on biology and clinical impact of occult hepatitis B virus infection

  Journal of Hepatology · 2019 · https://doi.org/10.1016/j.jhep.2019.03.034

• Identification of Four Immune Subtypes Characterized by Distinct Composition and Functions of Tumor Microenvironment in Intrahepatic Cholangiocarcinoma

  Hepatology · 2019 · https://doi.org/10.1002/hep.31092

• Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

  The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(18)32111-1

• Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry

  Journal of Hepatology · 2018 · https://doi.org/10.1016/j.jhep.2018.06.010

• Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

  The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30683-6

• Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

  The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30683-6

• Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients

  Transplantation · 2017 · https://doi.org/10.1097/tp.0000000000001651

• EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure

  Journal of Hepatology · 2017 · https://doi.org/10.1016/j.jhep.2016.12.003

• Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

  The Lancet Infectious Diseases · 2016 · https://doi.org/10.1016/s1473-3099(16)00052-9

• Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper

  Annals of Oncology · 2015 · https://doi.org/10.1093/annonc/mdv623

• Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis

  Gastroenterology · 2014 · https://doi.org/10.1053/j.gastro.2014.03.051

• Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation

  Gastroenterology · 2014 · https://doi.org/10.1053/j.gastro.2014.10.001

• Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure

  Journal of Hepatology · 2014 · https://doi.org/10.1016/j.jhep.2014.06.012

• The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure

  Journal of Hepatology · 2014 · https://doi.org/10.1016/j.jhep.2014.11.012

• Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014

  Hepatology International · 2014 · https://doi.org/10.1007/s12072-014-9580-2

• Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890

  Journal of Hepatology · 2013 · https://doi.org/10.1016/j.jhep.2013.04.035

• Early Liver Transplantation for Severe Alcoholic Hepatitis

  New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1105703

• Progression of Alphafetoprotein Before Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: A Critical Factor

  American Journal of Transplantation · 2009 · https://doi.org/10.1111/j.1600-6143.2009.02750.x

• Statements from the Taormina expert meeting on occult hepatitis B virus infection

  Journal of Hepatology · 2008 · https://doi.org/10.1016/j.jhep.2008.07.014

• Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus

  Hepatology · 2007 · https://doi.org/10.1002/hep.21990

• Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: A retrospective multicenter study

  Gastroenterology · 2002 · https://doi.org/10.1053/gast.2002.32364

• Hepatitis B Immune Globulin to Prevent Hepatitis B Virus Graft Reinfection Following Liver Transplantation: A Concise Review

  Hepatology · 2000 · https://doi.org/10.1053/jhep.2000.19789

• Orthotopic Liver Transplantation in Fulminant and Subfulminant Hepatitis The Paul Brousse Experience

  Annals of Surgery · 1995 · https://doi.org/10.1097/00000658-199508000-00002

• Liver Transplantation in European Patients with the Hepatitis B Surface Antigen

  New England Journal of Medicine · 1993 · https://doi.org/10.1056/nejm199312163292503

Current projects

No projects listed.